Patent Assignment
Reel/Frame 013897/0053
Assignment of Assignor's Interest
Recorded: 2003-04-08
Pages: 17
Assignor
ALLERGAN SALES, INC. (MERGED INTO ALLERGAN SALES, LLC)
Executed: 2003-04-01
Assignee
ALLERGAN, INC.
2525 DUPONT DRIVE, IRVINE, CALIFORNIA, 92612
Covered Properties
(94)
Retinoid Induced Gene
Patent:
6,294,657 →
Application:
08/996,533 →
Pharmaceutical Compositions Containing Buffered Ortho Ester Polymers
Patent:
6,440,460 →
Application:
09/117,359 →
Use of Platelet Activating Factor Antagonists as Anti-Pruritic Agents
Patent:
6,277,846 →
Application:
09/138,967 →
Tetrahdroquinolin-2-One 6 or 7-Yl, Tetrahdroquinilin-2-Thione 6 or 7-Yl Pentadienoic Acid and Related Derivatives Having Retinoid-Like Biological Activity
Patent:
6,048,873 →
Application:
09/164,949 →
2,4-Pentadienoic Acid Derivatives Having Selective Activity for Retinoid X (Rxr) Receptors
Patent:
6,147,224 →
Application:
09/164,950 →
Cyclopentane(Ene)Oic Acid, 2-Alkenyl Derivatives as Therapeutic Agents
Patent:
6,258,844 →
Application:
09/194,457 →
Method of Using (2-Imidazolin-2-Ylamino) Quinoxoalines in Treating Neural Injury
Patent:
6,194,415 →
Application:
09/225,036 →
Method and Composition for Treating Acne
Patent:
6,262,117 →
Application:
09/252,318 →
Capsule System
Patent:
6,248,354 →
Application:
09/262,623 →
Nucleic Acid Encoding a Human Ep Prostaglandin Receptor
Patent:
6,395,878 →
Application:
09/267,423 →
Inhibition of Noninactivating Na Channels of Mammalian Optic Nerve as a Means of Preventing Optic Nerve Degeneration Associated with Glaucoma
Patent:
6,326,389 →
Application:
09/273,832 →
Methods and Compositions for Drug Delivery
Patent:
6,350,780 →
Application:
09/286,147 →
Ocular Treatment Using Cyclosporin-a Derivatives
Patent:
6,254,860 →
Application:
09/290,833 →
Oxygen, Sulfur and Nitrogen Substituted Cyclohexene and Cyclohexane Derivatives Having Retinoid-Like Biological Activity
Patent:
6,166,244 →
Application:
09/307,061 →
Process for Preparing Substituted Benzo[1,2-G]-Chrom-3-Ene, Benzo[1,2-G]-Thiochrom-3-Ene and Benzo[1,2-G]-1,2-Dihydroquinoline Derivatives
Patent:
6,043,381 →
Application:
09/307,062 →
1- Alkoxy and 1-Acyloxy Substituted Cyclohex-1-Ene Compounds and Sulfur and 1-Alkoxycarbonyl Analogs Having Retinoid-Like Biological Activity
Patent:
6,177,588 →
Application:
09/307,073 →
Antibiotic Compositions and Method for Using Same
Patent:
6,166,012 →
Application:
09/365,291 →
Amines Substituted with a Dihydro-Benzofuranyl or with a Dihydro-Isobenzofuranyl Group, an Aryl or Heteroaryl Group and an Alkyl Group, Having Retinoid-Like Biological Activity
Patent:
6,093,838 →
Application:
09/375,845 →
Amines Substituted with a Tetrahydroquinolinyl Group an Aryl or Heteroaryl Group and an Alkyl Group, Having Retinoid-Like Biological Activity
Patent:
6,127,382 →
Application:
09/375,846 →
Preserved Cyclodextrin-Containing Compositions
Patent:
6,358,935 →
Application:
09/388,968 →
Methods for Treating Pain
Patent:
6,113,915 →
Application:
09/417,195 →
Method for Treating Otic Disorders
Patent:
6,265,379 →
Application:
09/418,192 →
Combinations of Prostaglandins and Brimonidine or Derivatives Thereof
Patent:
6,294,563 →
Application:
09/440,379 →
Calcium Blockers to Treat Proliferative Vitreoretinopathy
Patent:
6,380,261 →
Application:
09/445,832 →
Method for Treating Cancer with a Neurotoxin
Patent:
6,139,845 →
Application:
09/454,842 →
Use of Retinoid Receptor Antagonists in the Treatment of Cartilage and Bone Pathologies
Patent:
6,313,168 →
Application:
09/464,344 →
Methods for Treating Pancreatic Disorders
Patent:
6,143,306 →
Application:
09/482,831 →
Methods for treating diabetes
Patent:
6,337,075 →
Application:
09/491,420 →
Process for preparing substituted benzo[1,2-G]-chrome-3-ene, benzo[1,2-G]-thiochrom-3-ene and benzo[1,2-G]-1,2-dihydroquinoline derivatives
Patent:
6,211,385 →
Application:
09/492,492 →
Ocular hypotensive lipids
Patent:
6,395,787 →
Application:
09/500,142 →
Method for treating thyroid disorders
Patent:
6,524,580 →
Application:
09/504,538 →
Method for treating hashimoto's thyroiditis
Patent:
6,358,513 →
Application:
09/512,110 →
Storage and Delivery of Multi-Dose, Preservative-Free Pharmaceuticals
Patent:
6,450,994 →
Application:
09/526,052 →
2,4-Pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
Patent:
6,403,638 →
Application:
09/532,677 →
Methods and compositions for the treatment and prevention of lung disease
Patent:
6,303,648 →
Application:
09/548,897 →
Methods and Compositions for the Treatment and Prevention of Lung Disease
Patent:
6,492,414 →
Application:
09/549,226 →
Methods for Treating Pain by Administration of a Botulinum Toxin
Patent:
6,464,986 →
Application:
09/550,371 →
Intraspinal methods for treating pain
Patent:
6,235,289 →
Application:
09/578,097 →
Methods for treating pain with a modified neurotoxin
Patent:
6,333,037 →
Application:
09/578,181 →
Implant device with a retinoid for improved biocompatibility
Patent:
6,306,426 →
Application:
09/587,485 →
Organosilyl Compounds Having Nuclear Hormone Receptor Modulating Activity
Patent:
6,452,032 →
Application:
09/591,042 →
Male Anti-Fertility Agents
Patent:
6,521,641 →
Application:
09/591,253 →
Method for treating a pancreatic disorder with a neurotoxin
Patent:
6,261,572 →
Application:
09/629,748 →
Method for treating a catecholamine secretion
Patent:
6,350,455 →
Application:
09/631,029 →
Method for treating cancer with a neurotoxin to improve patient function
Patent:
6,368,605 →
Application:
09/631,030 →
1-Alkoxy and 1-Acyloxy Substituted Cyclohex-1-Ene Compounds and Sulfur and 1-Alkoxycarbonyl Analogs Having Retinoid-Like Biological Activity
Patent:
6,465,646 →
Application:
09/634,726 →
Oxygen, Sulfur and Nitrogen Substituted Cyclohexene and Cyclohexane Derivatives Having Retinoid-Like Biological Activity
Patent:
6,465,647 →
Application:
09/634,727 →
Compounds having activity as inhibitors of cytochrome P450RAI
Patent:
6,291,677 →
Application:
09/651,001 →
Compounds having activity as inhibitors of cytochrome P450RAI
Patent:
6,303,785 →
Application:
09/651,003 →
Compounds having activity as inhibitors of cytochrome P450RAI
Patent:
6,369,261 →
Application:
09/651,004 →
Compounds Having Activity as Inhibitors of Cytochrome P450RAI
Patent:
6,387,951 →
Application:
09/651,234 →
Compounds Having Activity as Inhibitors of Cytochrome P450RAI
Patent:
6,380,256 →
Application:
09/651,564 →
Compounds having activity as inhibitors of Cytochrome P450RAI
Patent:
6,369,225 →
Application:
09/651,566 →
Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
Patent:
6,248,741 →
Application:
09/655,579 →
Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents
Patent:
6,248,783 →
Application:
09/665,791 →
Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents
Patent:
6,291,522 →
Application:
09/671,492 →
Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
Patent:
6,313,107 →
Application:
09/672,751 →
Methods for Treating Muscle Injuries
Patent:
6,423,319 →
Application:
09/678,189 →
Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
Patent:
6,329,369 →
Application:
09/679,919 →
Antibiotic Compositions and Methods for Using Same
Patent:
6,492,361 →
Application:
09/680,810 →
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
Patent:
6,376,533 →
Application:
09/693,722 →
Method for treating hyperparathyroidism
Patent:
6,328,977 →
Application:
09/704,440 →
Method for treating hypercalcemia
Patent:
6,319,506 →
Application:
09/704,441 →
Method for Treating Hypercalcemia
Patent:
6,447,785 →
Application:
09/706,174 →
Twist Housing Apparatus for Instilling a Medication into an Eye
Patent:
6,533,764 →
Application:
09/707,006 →
(2-Hydroxy)Ethyl-Thioureas Useful as Modulators of ALPHA2B Adrenergic Receptors
Intraspinal botulinum toxin for treating pain
Treatment of Tumors with Raralpha Selective Retinoid Compounds in Combination with Other Anti-Tumor Agents
Compounds Having Activity as Inhibitors of Cytochrome P450RAI
Patent:
6,399,774 →
Application:
09/829,097 →
Compounds having activity as inhibitors of cytochrome P450RAI
Patent:
6,359,135 →
Application:
09/829,098 →
Lactam Compounds for Penetration Enhancement
Interheteroaryl 7-Oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2alpha antagonists
Patent:
6,369,089 →
Application:
09/840,675 →
Cholinergic Agents in the Treatment of Presbyopia
Patent:
6,410,544 →
Application:
09/842,299 →
Cyclopentane, 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents
Patent:
6,307,092 →
Application:
09/850,834 →
3,7 or 3 and 7 Thia or Oxa Prostanoic Acid Derivatives as Agents for Lowering Intraocular Pressure
Patent:
6,410,591 →
Application:
09/851,296 →
Prostanoic Acid Derivatives as Agents for Lowering Intraocular Pressure
Neurotoxin Therapy for Inner Ear Disorders
Ocular treatment using cyclosporin-A derivatives
Methods of Providing and Using Compounds Having Activity as Inhibitors of Cytochrome P450RAI
Patent:
6,387,892 →
Application:
09/875,967 →
Cyclopentane Heptan(Ene)Oic Acid, 2-Thiocarbamoyloxy and 2-Carbamoyloxy Compounds as Therapeutic Agents
Cyclopentane Heptan(Ene) Acyl Sulfonamide, 2-Alkyl or 2-Arylalkyl, or 2-Heteroarylalkenyl Derivatives as Therapeutic Agents
Patent:
6,476,064 →
Application:
09/880,272 →
Cyclopentane Heptan(Ene)Oic Acid, 2-Thiocarbamoyloxy and 2-Carbamoyloxy Compounds as Therapeutic Agents
Patent:
6,380,251 →
Application:
09/903,971 →
Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents
Patent:
6,359,181 →
Application:
09/915,908 →
Clostridial Toxin Derivatives and Methods for Treating Pain
Implant Device with a Retinoid for Improved Biocompatibility
Patent:
6,455,062 →
Application:
09/935,360 →
Inhibition of Noninactivating Na Channels of Mammalian Optic Nerve as a Means of Preventing Optic Nerve Degeneration Associated with Glaucoma
Inhibition of Noninactivating Na Channels of Mammalian Optic Nerve as a Means of Preventing Optic Nerve Degeneration Associated with Glaucoma
Methods of Providing and Using Compounds Having Activity as Inhibitors of Cytochrome P450RAI
Benzofuran, Indole or Benzothiophene 2,4-Pentadienoic Acid Derivatives Having Selective Activity for Retinoid X (Rxr) Receptors
Patent:
6,388,105 →
Application:
09/967,130 →
Neurotoxin Therapy for Diabetes
Implant Device with a Retinoid for Improved Biocompatibility
Compounds Having Activity as Inhibitors of Cytochrome P450RAI
Targeting the Reverse Mode of the Na+/CA2+ Exchanger for the Treatment of Optic Neuropathy Associated with Glaucoma and Ischemic Optic Neuropathy
Patent:
6,479,458 →
Application:
10/005,829 →
Interheteroaryl 7-Oxabicyclic [2.2.1]Heptane Oxazoles as Prostaglandin F2ALPHA Antagonists
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 27, 1998
From: ZIGNANI, MONIA; TABATABAY, CYRUS
To: GURNY, ROBERT
Reel/Frame 009485/0602 →
Assignment of Assignor's Interest
Sep 14, 1998
From: WOODWARD, DAVID F.; WILLIAMS, LINDA SUE
To: ALLERGAN SALES, INC.
Reel/Frame 009451/0332 →
Assignment of Assignor's Interest
Oct 1, 1998
From: VASUDEVAN, JAYASREE; VULIGONDA, VIDYASAGAR; BEARD, RICHARD L.; CHANDRARATNA, ROSHANTHA A.
To: ALLERGAN SALES, INC.
Reel/Frame 009512/0950 →
Assignment of Assignor's Interest
Nov 6, 1998
From: VULIGONDA, VIDYASAGAR; TSANG, KWOK YIN; VASUDEVAN, JAYASREE; CHANDRARATNA, ROSHANTHA A.
To: ALLERGAN SALES, INC.
Reel/Frame 009575/0291 →
Assignment of Assignor's Interest
Feb 18, 1999
From: SEFTON, JOHN
To: ALLERGAN SALES, INC.
Reel/Frame 009782/0732 →
Assignment of Assignor's Interest
Mar 4, 1999
From: FIRESTONE, BRUCE A.; TRAN, THAO T.
To: ALLERGAN SALES, INC.
Reel/Frame 009825/0375 →
Assignment of Assignor's Interest
Mar 22, 1999
From: ADORANTE, JOSEPH S.
To: ALLERGAN SALES, INC.
Reel/Frame 009846/0139 →
Assignment of Assignor's Interest
May 3, 1999
From: WHEELER, LARRY A.; WOLDEMUSSIE, ELIZABETH; LAI, RONALD K.
To: ALLERGAN SALES, INC.
Reel/Frame 009941/0610 →
Assignment of Assignor's Interest
May 7, 1999
From: VULIGONDA, VIDYSAGAR; CHANDRARATNA, ROSHANTHA A.
To: ALLERGAN SALES, INC.
Reel/Frame 009971/0686 →
Assignment of Assignor's Interest
May 7, 1999
From: BEARD, RICHARD L.; COLON, DIANA F.; CHANDRARATNA, ROSHANTHA A.
To: ALLERGAN SALES, INC.
Reel/Frame 009955/0660 →
Assignment of Assignor's Interest
May 7, 1999
From: BEARD, RICHARD L.; COLON, DIANA F.; CHANDRARATNA, ROSHANTHA A.
To: ALLERGAN SALES, INC.
Reel/Frame 009953/0834 →
Assignment of Assignor's Interest
May 10, 1999
From: GIL, DANIEL W.; WOODWARD, DAVID F.
To: ALLERGAN SALES, INC.
Reel/Frame 009951/0267 →
Assignment of Assignor's Interest
May 10, 1999
From: REGAN, JOHN W.
To: ARIZONA BOARD OF REGENTS THE UNIVERSITY OF ARIZONA
Reel/Frame 009951/0278 →
Assignment of Assignor's Interest
May 17, 1999
From: GARST, MICHAEL E.; ADORANTE, JOSEPH S.
To: ALLERGAN SALES, INC.
Reel/Frame 009957/0647 →
Assignment of Assignor's Interest
Jun 2, 1999
From: GARST, MICHAEL E.
To: ALLERGAN SALES, INC
Reel/Frame 009994/0590 →
Assignment of Assignor's Interest
Jul 30, 1999
From: POWER, DAVID F.; MULLER, CHRISTOPHER A.; BANCROFT, ELIZABETH A.; CHEETHAM, JANET K.
To: ALLERGAN SALES, INC.
Reel/Frame 010150/0312 →
Assignment of Assignor's Interest
Aug 16, 1999
From: VASUDEVAN, JAYASREE; BEARD, RICHARD L.; HUANG, DEHUA; CHANDRARATNA, ROSHANTHA A.
To: ALLERGAN SALES, INC.
Reel/Frame 010178/0760 →
Assignment of Assignor's Interest
Aug 16, 1999
From: BEARD, RICHARD L.; JEON, RAOK; COLON, DIANA F.; CHANDRARATNA, ROSHANTHA A.
To: ALLERGAN SALES, INC.
Reel/Frame 010213/0904 →
Assignment of Assignor's Interest
Sep 2, 1999
From: BECK, GARY J.; KERSLAKE, EDWARD D.S.; OLEJNIK, OREST
To: ALLERGAN SALES, INC.
Reel/Frame 010225/0771 →
Assignment of Assignor's Interest
Nov 30, 1999
From: GARST, MICHAEL E.
To: ALLERGAN SALES, INC.
Reel/Frame 011717/0317 →
Assignment of Assignor's Interest
Dec 13, 1999
From: DREYER, EVAN B.
To: ALLERGAN SALES, INC.
Reel/Frame 010636/0294 →
Assignment of Assignor's Interest
May 1, 2000
From: DONOVAN, STEPHEN
To: ALLERGAN SALES, INC.
Reel/Frame 010780/0119 →
Assignment of Assignor's Interest
May 1, 2000
From: DONOVAN, STEPHEN
To: ALLERGAN SALES, INC.
Reel/Frame 010780/0078 →
Assignment of Assignor's Interest
May 4, 2000
From: AOKI, KEI ROGER; CUI, MINGLEI
To: ALLERGAN SALES, INC.
Reel/Frame 011040/0239 →
Exclusive License
May 9, 2001
From: ALLERGAN, INC.; ALLERGAN SALES, INC.; ALLERGAN AMERICA, INC.; ALLERGAN PHARMACEUTICALS (IRELAND), LTD.
To: BARDEEN SCIENCES COMPANY, LLC
Reel/Frame 011783/0633 →